These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis. de la Torre Hernández JM, Garcia Camarero T, Lozano Ruiz-Poveda F, Urbano-Carrillo CA, Sánchez Pérez I, Cano-García M, Saez R, Andrés Morist A, Molina E, Pinar E, Torres A, Lezcano EJ, Gutierrez H, Arnold RJ, Zueco J. Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071 [Abstract] [Full Text] [Related]
47. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study. Ambrosini V, Golino L, Niccoli G, Roberto M, Lisanti P, Ceravolo R, Bernardi G, Armigliato P, Gabrielli G, Chizzola G, De Paulis C, Crea F, Colombo A. Cardiovasc Revasc Med; 2017 Jan; 18(3):165-168. PubMed ID: 28081977 [Abstract] [Full Text] [Related]
48. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis. Breuckmann F, Naber C, Beckert J, Schmermund A, Haude M, Baumgart D, Erbel R. Int J Cardiol; 2006 Mar 22; 108(1):20-5. PubMed ID: 16516694 [Abstract] [Full Text] [Related]
52. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease. Kurtul A, Murat SN, Yarlioglues M, Duran M, Karadeniz M, Ergun G, Akyel A, Mendi MA, Oksuz F. Platelets; 2015 Sep 03; 26(1):48-52. PubMed ID: 24831828 [Abstract] [Full Text] [Related]
53. Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo. Iaconetti C, De Rosa S, Polimeni A, Sorrentino S, Gareri C, Carino A, Sabatino J, Colangelo M, Curcio A, Indolfi C. Cardiovasc Res; 2015 Sep 01; 107(4):522-33. PubMed ID: 25994172 [Abstract] [Full Text] [Related]
55. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents. Wu XA, Xie G, Li XQ, Wu HT, Wang X. Clin Chim Acta; 2018 Apr 01; 479():20-24. PubMed ID: 29305846 [Abstract] [Full Text] [Related]
56. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus. Chiam K, Mayne GC, Wang T, Watson DI, Irvine TS, Bright T, Smith LT, Ball IA, Bowen JM, Keefe DM, Thompson SK, Hussey DJ. World J Gastroenterol; 2020 May 28; 26(20):2570-2583. PubMed ID: 32523312 [Abstract] [Full Text] [Related]
57. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. Kang SJ, Cho YR, Park GM, Ahn JM, Han SB, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Mintz GS, Park SJ. JACC Cardiovasc Imaging; 2013 Nov 28; 6(11):1183-90. PubMed ID: 24229771 [Abstract] [Full Text] [Related]
58. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Stojkovic S, Jurisic M, Kopp CW, Koppensteiner R, Huber K, Wojta J, Gremmel T. Atherosclerosis; 2018 Feb 28; 269():197-203. PubMed ID: 29366993 [Abstract] [Full Text] [Related]